To obtain a medicine for treating vomit induced by cancer chemotherapeutics, radiation hangover, etc. by adding a tachykinin antagonist useful for treating various disorders such as inflammatory diseases, allergic syndromes, etc. as an active ingredient.
This medicine contains a tachykinin antagonist {preferably 2-ammonium-1-[[3,5-bis(trifluoromethyl)phenyl]methyloxy]-3,3-diphenylpropane, (2S,3S)-3-(2-methoxy-5-trifluoromethoxybenzyl)-amino-2-phenylpiperidine}, such as a compound of the formula [(n) is 1-3: X is O or S; R1 is a 1-6C alkyl, a 2-6C alkenyl, a 2-6C alkynyl, a halogen, cyano, nitro or the like; R2 is phenyl, naphthyl, indazolyl, thienyl, furyl or the like; R4, R5 are each H, a halogen, a 1-6C alkyl, oxo or the like; and R8 is H, a 1-6C alkyl or the like], as an active ingredient.
BUNCE KEITH T
